Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile

GlobalData
40 Pages - GLDATA61704
$250.00

Summary

Genomic Health Inc (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in the US, Europe, and Asia through its subsidiaries and offices. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Genomic Health Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Genomic Health Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Genomic Health Inc, Medical Equipment, Deal Details 12
Venture Financing 12
InVitae Raises USD120 Million in Series F Venture Financing 12
Invitae Raises US$40 Million In Series E Financing 13
Partnerships 15
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 15
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 15
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 17
Genomic Health and Epic Sciences Enter into Distribution Agreement 18
Philips Electronics Enters into Agreement with Genomic Health 19
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 19
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 20
Equity Offering 21
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 21
Genomic Health Inc - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 26
Nov 01, 2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results 28
Aug 02, 2016: Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial Results, Raises Low End of Full-Year Test and Revenue Guidance 30
May 04, 2016: Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results 32
Feb 10, 2016: Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results 33
Product News 35
03/11/2016: Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX in Node-positive and High-risk Node-negative Breast Cancer 35
03/09/2016: German National Cancer Guidelines Distinguish Oncotype DX as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence 36
03/01/2016: Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX 37
01/11/2016: Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016 38
Other Significant Developments 39
Jan 08, 2016: Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Genomic Health Inc, Medical Equipment, Key Facts, 2015 1
Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Genomic Health Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Genomic Health Inc, Deals By Market, 2011 to YTD 2017 9
Genomic Health Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
InVitae Raises USD120 Million in Series F Venture Financing 12
Invitae Raises US$40 Million In Series E Financing 13
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 15
Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 15
NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 17
Genomic Health and Epic Sciences Enter into Distribution Agreement 18
Philips Electronics Enters into Agreement with Genomic Health 19
Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 19
Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 20
Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To US$334 Million 21
Genomic Health Inc, Key Competitors 23
Genomic Health Inc, Key Employees 24
Genomic Health Inc, Other Locations 25
Genomic Health Inc, Subsidiaries 25

List of Figures
Genomic Health Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Genomic Health Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Genomic Health Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Genomic Health Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Genomic Health Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838